IDO inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9765018
SERIAL NO

14897668

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

There are disclosed compounds of formula (I) that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BRISTOL-MYERS SQUIBB COMPANYPRINCETON NJ

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Balog, James Aaron Lambertville, US 67 785
Hart, Amy C Ewing, US 19 80
Huang, Audris New Hope, US 36 163
Inghrim, Jennifer Plainsboro, US 6 61
Mandal, Sunil Kumar Bangalore, IN 7 36
Markwalder, Jay A Lahaska, US 27 212
Seitz, Steven P Swarthmore, US 35 235
Williams, David K Delran, US 46 533

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 19, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 19, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00